TAIHO PHARMACEUTICAL CO., LTD.
Patent Owner
Stats
- 97 US PATENTS IN FORCE
- 13 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 97 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,753 Total Citation Count
- Jul 12, 1976 Earliest Filing
- 172 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0252,307 DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY AMELIORATING AGENTMay 19, 17Sep 07, 17[A61K]
2017/0112,866 ANTI-TUMOR AGENT CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCERApr 03, 15Apr 27, 17[A61K]
2016/0193,210 ANTITUMOR DRUG FOR INTERMITTENT ADMINISTRATION OF FGFR INHIBITORJul 17, 14Jul 07, 16[A61K]
2016/0082,032 THERAPEUTIC EFFECT PREDICTION METHOD FOR COLORECTAL CANCER PATIENT IN WHOM EXPRESSION OF TK1 PROTEIN HAS INCREASEDMay 16, 14Mar 24, 16[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9845329 Method for producing a substituted 6,7,8,9-tetrahydropyrimido[5,4-b]indolizine, substituted 7,8,9,10-tetrahydro-6H-pyrimido[5′,4′:4,5]pyrrolo[1,2-a]azepine and substituted 6,7,8,9,10,11-hexahydropyrimido[5′,4′:4,5]pyrrolo[1,2-a]azocineFeb 21, 14Dec 19, 17[C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0035,705 DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY AMELIORATING AGENTAbandonedAug 04, 15Feb 09, 17[A61K]
9289431 Antitumor effect potentiator composed of imidazooxazine compoundWithdrawnJul 01, 13Mar 22, 16[A61K, C07D]
2015/0110,864 NOVEL ANTITUMOR AGENT COMPRISING COMBINATION OF THREE AGENTSAbandonedMar 15, 13Apr 23, 15[A61K]
2014/0038,966 TEGAFUR-CONTAINING COMPOSITION FOR SINGLE DAILY AND ALTERNATE-DAY DOSINGAbandonedJan 30, 12Feb 06, 14[A61K]
8642572 Cytidine derivative-containing antitumor agent for continuous intravenous administrationExpiredApr 04, 08Feb 04, 14[A61K, C07H]
8598188 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancerExpiredMar 08, 10Dec 03, 13[A61K]
8586561 Anti-tumor agent comprising cytidine derivative and carboplatinExpiredMar 26, 09Nov 19, 13[A61K, A01N]
8557791 Anti-tumor agent comprising cytidine derivative and carboplatinWithdrawnMar 26, 09Oct 15, 13[A61K, A01N]
8440398 Method for prediction of sensitivity to 5-fluorouracil-type anticancer agentExpiredJan 23, 07May 14, 13[C12Q]
2013/0116,298 ANTITUMOR AGENT OR POSTOPERATIVE ADJUVANT CHEMOTHERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA TREATMENTAbandonedDec 24, 10May 09, 13[A61K]
8329150 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the sameExpiredFeb 24, 11Dec 11, 12[A61K, C07C, G01N, A61P]
2012/0264,803 METHOD FOR PREDICTING THERAPEUTIC EFFECTS OF CHEMOTHERAPY ON HEPATOCELLULAR CARCINOMA PATIENTSAbandonedDec 24, 10Oct 18, 12[A61K, C12Q, C07D, A61P]
8188105 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredientExpiredOct 10, 08May 29, 12[A61K]
2012/0059,009 ANTI-TUMOR AGENT CONTAINING TEGAFUR-GIMERACIL-OTERACIL POTASSIUM COMBINATION DRUG AND OXALIPLATINAbandonedMay 11, 10Mar 08, 12[A61K, A61P]
2011/0172,184 ANTITUMOR AGENT CONTAINING 4 - [[3,5 - BIS (TRIMETHYLSILYL) BENZOYL] AMINO] BENZOIC ACIDAbandonedSep 15, 09Jul 14, 11[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.